Abstract
A pharmacokinetic model was developed for the renal imaging agent9mTc-DMSA in anesthetized rats, which incorporated data from serial measurements of blood and urine simultaneously with dynamic images obtained over an 8-h period. Animals which received a 10 mg/kg dose of unlabeled DMSA immediately before99mTc-DMSA injection had a significantly reduced kidney accumulation and greater urinary elimination of99mTc than animals which received the radiopharmaceutical alone. The kidney clearance was also significantly lower in rats receiving unlabeled DMSA, but no significant difference was determined between the urine clearance estimates of the two animal groups. Because the increase in the amount eliminated in the urine was not coupled with a significant change in urine clearance, it would appear that unlabeled DMSA saturated the kidney uptake mechanism(s) of99mTc-DMSA without modifying the urinary clearance process. This interpretation is consistent with the hypothesis that renal handling of99m'Tc-DMSA is governed by both glomerular filtration and peritubular capillary uptake. The simultaneous acquisition of blood, urine and non invasive image data allows for a comprehensive and informative model of the physiological disposition of99mTc-DMSA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arnold RW, Subramanian G, McAfee JG, Blair RJ, Thomas FD (1975) Comparison of Tc-99m complexes for renal imaging. J Nucl Med 16:357–367
Bingham JB, Maisey MN (1978) An evaluation of the use of Tc-99m dimercaptosuccinic acid (DMSA) as a static renal imaging agent. Br J Radiol 51:599–607
Brechner RR, D'Argenio DZ, Dahalan R, Wolf W (1986) Noninvasive estimation of bound and mobile platinum compounds in the kidney using a radiopharmacokinetic model. J Pharm Sci 75:873–877
D'Argenio DZ, Schumitzky A (1979) A program package for simulation and parameter estimation in pharmacokinetic systems. Comput Programs Biomed 9:115–134
de Lange MJ, Piers DA, van Luijk WHJ, Meijer S (1988) Renal handling of Tc-99m DMSA: Peritubular uptake or glomerular filtration and reabsorption. J Nucl Med 29:778
Dewanjee MK (1982) Binding of diagnostic radiopharmaceuticals to human serum albumin by sequential and equilibrium dialysis. J Nucl Med 23:753–754
Draper NR, Smith H (1981) Applied regression analysis, 2nd Ed. Wiley, New York, pp 47–49
Enlander D, Weber PM, dos Remedios LV (1974) Renal cortical imaging in 35 patients: Superior quality with Tc-99m DMSA. J Nucl Med 15:743–749
Gibaldi M, Perrier D (1982) Pharmacokinetics. Dekker, New York
Godley ML, Ransley PG, Gordon I, Risdon RA, Vivian G, ToddPokropek A (1985) The relationship between renal parenchymal mass and absolute quantitation of Tc-99m DMSA uptake. An experimental study in the growing pig. Nucl Med Commun 6:377–388
Goldraich NP, Alvarenga AR, Goldraich III, Ramos OL, Sigulem D (1985) Renal accumulation of Tc-99m DMSA in the artificially perfused isolated rat kidney. J Urol 134:1282–1286
Gordon I, Evans K, Peters AM, Kelly J, Morales BN, Goldraich N, Yau A (1987) The quantitation of Tc-99m DMSA in paediatrics. Nucl Med Commun 8:661–670
Ikeda I, Inoue O, Kurata K (1977a) Chemical and biological studies on Tc-99m DMS-I: Formation of complexes by four different methods. Int J Nucl Med Biol 4:565
Ikeda I, Inoue O, Kurata K (1977b) Preparation of various Tc-99m dimercaptosuccinate complexes and their evaluation as radiotracers. J Nucl Med 18:1222–1229
Kawamura J, Hosokawa S, Yoshida O, Fujita T, Ishii Y, Torizuka K (1978) Validity of Tc-99m dimercaptosuccinic acid renal uptake for an assessment of individual kidney function. J Urol 119:305–309
Liang Y, Marlowe C, Waddell WJ (1986) Disposition of C-14 dimercaptosuccinic acid in mice. Fundam Appl Toxicol 6:532–540
Lin TH, Khentigan A, Winchell HS (1974) A Tc-99m chelate substitute for organoradiomercurial renal agents. J Nucl Med 15:34–35
Luijk WHJ van, Ensing GJ, Meijer S, Donker AJM, Piers DA (1984) Is the relative Tc-99m DMSA clearance a useful marker of proximal tubular dysfunction? Eur J Nucl Med 9:439–442
Maneval DC (1988) A pharmacoknetic study of the renal imaging agent Tc-99m DMSA in the rat. PhD thesis, University of Southern California
McAfee JG, Subramanian G (1983) Experimental models and evaluation of animal data for renal radiodiagnostic agents. In: Lambrecht RM, Eckelman WC (eds) Animals models in radiotracer design. Springer, New York Berlin Heidelberg, pp 211–227
McAfee JG, Thomas FD, Subramanian G, Lyons B, Roskopf M (1986) Detection of diffuse glomerular lesions in rats: I. Comparisons of conventional radioactive agents. J Nucl Med 27:502–512
McAfee JG, Kopecky RT, Thomas FD, Hellwig B, Roskopf M (1988) Comparison of different radioactive agents for the detection of renovascular hypertension with captopril in a rat model. J Nucl Med 29:509–515
Millar AM (1984) The adsorption of Tc-99m dimercaptosuccinic acid onto injection vials. Nucl Med Commun 5:195–199
Moretti JL, Rapin JR, Le Pocin M, Lageron A, Saccavini JC, Bardy A (1982) Dimercapto-succinic acid complexes: Their structure, biological behaviour and renal localization. In: Joekes AM, Constable AR, Brown NJG, Tauxe WN (eds) Radionuclides in nephrology. Academic Press, New York, pp 25–31
Moretti JL, Rapin JR, Saccavini JC, Lageron A, Le Poncin M, Bardy A (1984a) 2,3-dimercaptosuccinic-acid chelates — 1. Structure and pharmacokinetic studies. Int J Nucl Med Biol 11:270–274
Moretti JL, Rapin JR, Saccavini JC, Lageron A, Le Poncin M, Bardy A (1984b) 2,3-dimercaptosuccinic-acid chelates — 2. Renal localization. Int J Nucl Med Biol 11:275–279
Peters AM, Jones DH, Evans K, Gordon I (1988) Two routes for Tc-99m DMSA uptake into the renal cortical tubular cell. Eur J Nucl Med 14:555–561
Provoost AP, Van Aken M (1985) Renal handling of technetium-99m DMSA in rats with proximal tubular dysfunction. J Nucl Med 26:1063–1067
Provoost AP, Van Aken M (1986) The effect of DMSA loading on the renal handling of technetium-99m in rats. Uremia Invest 9:147–150
Ryan BF, Joiner BL, Ryan TA (1985) Minitab handbook, 2nd Ed. Duxbury Press, Boston
Sheiner LB, Beal SL (1980) Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-Menten model: Routine clinical pharmacokinetic data. J Pharmacokinet Biopharm 8:553–571
Steigman J, Chin EV, Solomon NA (1979) Scintiphotos in rabbits made with Tc-99m preparations reduced by electrolysis and by SnCl2: Concise communication. J Nucl Med 20:766–770
Taylor A, Lallone RL, Hagan PL (1980) Optimal handling of dimercaptosuccinic acid for quantitative renal scanning. J Nucl Med 21:1190–1193
Taylor A (1982) Quantitation of renal function with static imaging agents. Semin Nucl Med 12:330–344
Vanlic-Razumenic NM, Gorkic DA (1976) Studies of chemical and biological properties of Tc-99m DMS (dimercaptosuccinic acid) — renal imaging agent. Eur J Nucl Med 1:235–242
Vanlic-Razumenic N, Petrovic J, Gorkic D (1984) Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. IV Interaction of Tc-99m DMS and Tc-99m DMS complexes with blood serum proteins. Eur J Nucl Med 9:370–373
Yee CA, Lee HB, Blaufox MD (1981) Tc-99m DMSA renal uptake: Influence of biochemical and physiological factors. J Nucl Med 22:1054–1058
Zimmer AM, Pavel DG (1977) Rapid miniaturized chromatographic quality-control procedures for Tc-99m radiopharmaccuticals. J Nucl Med 18:1230–1233
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maneval, D.C., D'Argenio, D.Z. & Wolf, W. A kinetic model for99mTc-DMSA in the rat. Eur J Nucl Med 16, 29–34 (1990). https://doi.org/10.1007/BF01566009
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01566009